Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Amyris logo — Transforming industries with renewable biological chemistry

Amyris

Transforming industries with renewable biological chemistry

Founded 2003 United States Emeryville, United States 1002 employees IPO Total: $1.43B Biotechnology, Renewable Energy

General Information

Company Name Amyris
Founded Year 2003
Location United States Emeryville, United States
Founders / Decision Makers
Team member Team member
Employees 1002
Industries Biotechnology, Renewable Energy
Funding Stage IPO
Business Model B2B, D2C, B2B2C
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Amyris. To contact Amyris, visit amyris.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Amyris compare?

A PDF of Amyris and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Amyris soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Amyris

Amyris, headquartered in the United States, is paving the way in the realm of biotechnology and renewable energy with its innovative approach to renewable biological chemistry. Founded in 2003, the company leverages advanced fermentation technology to customize and manufacture specialty molecules for diverse industries including flavors, fragrances, beauty, personal care, and food.

Initially driven by a bold humanitarian goal of improving access to a lifesaving antimalarial compound, Amyris has evolved over two decades into a commercially successful enterprise. Its proprietary platform underscores a commitment to precision, consistency, and sustainability.

In its latest financial move, the company secured a $400 million Post-IPO debt investment on November 1, 2021. As Amyris continues to redefine industry standards, it presents a compelling proposition for investors interested in cutting-edge, sustainable biomanufacturing solutions.

Business keywords: biomanufacturing, specialty molecules, advanced fermentation technology, renewable biological chemistry, industrial synthetic biology, sustainable alternatives, biopharmaceutical drug discovery, renewable products, cosmetic ingredients, flavors and fragrances, advanced materials, personal care, chemical manufacturing, nutraceuticals

Services & Products

Strain Development
Process Development
Piloting and Scale-up
Manufacturing

Target Customers

Biotechnology Companies Personal Care Industry Chemical Manufacturers Sustainability-focused Entrepreneurs

Funding Rounds & Investors (23)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt $400.00M -
01 Nov 2021
Post-IPO Equity $300.00M -
01 Apr 2021
Post-IPO Equity $200.00M -
01 Jun 2020
Post-IPO Equity $34.00M 2
John Doerr, Wei-Wu He
01 Apr 2019
Post-IPO Equity $46.00M -
01 Aug 2018
Grant Undisclosed 1
National Institute of Health
National Institute of Health
01 Jan 2018
Post-IPO Equity $50.00M 1
DSM
01 Aug 2017
Post-IPO Equity Undisclosed -
01 Oct 2016
Post-IPO Equity $141.00M 1
Temasek
01 Jul 2015
Post-IPO Debt $10.90M -
01 Jul 2014

View All 23 Funding Rounds

Amyris Alternatives & Competitors

View All Alternatives
Amyris vs
CarbonBridge
CarbonBridge United States

Bioreactors for biofoundries

Seed
12 employees
Biotechnology, Renewable Energy
Amyris vs
Geo bio gas&carbon
Geo bio gas&carbon Brazil

Somos a energia do futuro, hoje!

123 employees
Biotechnology, Energy
Amyris vs
Avantium
Avantium The Netherlands

Avantium develops and commercializes innovative technologies for the production of materials based o...

Post-IPO Equity
290 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Amyris

Transforming industries with renewable biological chemistry
Amyris was founded in 2003.
Amyris is headquartered in Emeryville, United States.
Amyris operates in Biotechnology and Renewable Energy. Its work centres on biomanufacturing, specialty molecules, advanced fermentation technology and renewable biological chemistry. Its customers include Biotechnology Companies, Personal Care Industry and Chemical Manufacturers.
Amyris has a B2B, D2C and B2B2C business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Amyris has approximately 1002 employees.
Amyris has completed 23 funding rounds, raising a total of $1.43B. The latest funding stage is IPO.
Amyris offers: Strain Development, Process Development, Piloting and Scale-up, Manufacturing.
Top alternatives and competitors to Amyris include CarbonBridge, Geo bio gas&carbon, Avantium. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amyris and CarbonBridge are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Amyris, https://bouncewatch.com/company/amyris, updated 2 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes